Skip to content

Source filing unavailable

Q1 2017 · —
Revenue$14.85Mno prior Q1 2016 on file
Net Income-$1.11Mno prior Q1 2016 on file
EPS Diluted-$2.55no prior Q1 2016 on file
Margins · derived
Net margin-7.5%

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

no prior Q1 2016 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Sutro Biopharma, Inc. · CIK 1382101 · Engraved from SEC EDGAR